Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-17-000496
Filing Date
2017-02-02
Accepted
2017-02-02 16:30:17
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 a2230823z424b5.htm 424B5 728383
2 G697110.JPG g697110.jpg GRAPHIC 18108
  Complete submission text file 0001047469-17-000496.txt   754641
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-205484 | Film No.: 17568654
SIC: 2834 Pharmaceutical Preparations